JPRN-jRCTs052180032已完成3 期
arrowband ultraviolet B phototherapy for the treatment of pruritus induced by chronic liver disease and cholestasis - Narrowband ultraviolet B phototherapy for the treatment of pruritus induced by chronic liver disease and cholestasis
Takai Atsushi0 个研究点目标入组 2 人开始时间: 2019年1月29日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 2
研究概览
简要总结
Although statistical analysis was difficult because only two subjects were studied, one showed improvement of pruritic symptoms with narrowband UVB therapy, but one did not show long-term control and had flare-ups of symptoms after the end of irradiation.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients eligible for preregistration were those: (i) with
- •chronic liver disease or cholestasis including chronic hepatitis, cirrhosis, PSC, and PBC; (ii) who were at least 20 years of age at the time of
- •informed consent; (iii) mean VAS>50 mm in one week, or VAS of >20 mm on 5 or more days per week, or pruritus scores >3 on 4 or more days per week.
排除标准
- •Patients with psychiatric disorder, dementia, dermatosis, or chronic renal disease.
研究者
相似试验
招募中
不适用
arrowband ultraviolet B phototherapy for patients with uremic pruritusDiseases of the skin and subcutaneous tissueKCT0003701Kangdong Sacred Heart Hospital34
Unknown
2 期
PHOTOTHERAPY VERSUS PREGABALIN IN TREATMENT OF REFRACTORY UREAMIC PRURITISRefractory Uremic PruritisNCT04660773Alexandria University40
终止
3 期
Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.Nevoid Basal Cell Carcinoma SyndromeGorlin SyndromeBasal Cell CarcinomaNCT00049959QLT Inc.
已完成
2 期
Omalizumab in Severe and Refractory Solar UrticariaSolar UrticariaNCT02262130Centre Hospitalier Universitaire de Besancon10
终止
不适用
Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for VitiligoVitiligoPigmentationDyschromiaNCT02506101Johns Hopkins University2